HAEMONETICS CORP shareholders Q3 2023

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 1,873$167,7840.01%
ROYAL BANK OF CANADA 200,098$17,925,0000.01%
MORGAN STANLEY 504,403$45,184,4210.01%
Handelsbanken Fonder AB 9,395$8420.01%
LAZARD ASSET MANAGEMENT LLC 38,538$3,4520.01%
Zurcher Kantonalbank (Zurich Cantonalbank) 13,446$1,204,4930.01%
AdvisorNet Financial, Inc 447$40,0420.00%
MACQUARIE GROUP LTD 32,495$2,911,0000.00%
BNP PARIBAS FINANCIAL MARKETS 33,582$3,008,2760.00%
TWO SIGMA INVESTMENTS, LP 16,687$1,494,8210.00%
DEUTSCHE BANK AG\ 60,800$5,446,4640.00%
MARSHALL WACE, LLP 21,848$1,957,1440.00%
Leucadia National 4,741$424,6990.00%
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 4,302$385,3730.00%
CAPTRUST FINANCIAL ADVISORS 10,822$969,4350.00%
Mirae Asset Global Investments Co., Ltd. 22,036$1,973,9850.00%
LGT Financial Advisors LLC 31$2,7770.00%
NATIXIS ADVISORS, L.P. 15,495$1,3880.00%
ALLIANCEBERNSTEIN L.P. 112,502$10,077,9290.00%
FIRST TRUST ADVISORS LP 36,325$3,253,9930.00%
External links

This page lists HAEMONETICS CORP's shareholders in Q3 2023. To view HAEMONETICS CORP's shareholder history, click here.